Literature DB >> 23092108

Intravascular lymphoma of the central nervous system presenting as multiple cerebral infarctions.

Hiroyuki Momota1, Yoshitaka Narita, Yasuji Miyakita, Soichiro Shibui.   

Abstract

A 67-year-old woman presented with an acute onset of left-sided weakness. Magnetic resonance (MR) imaging revealed multiple cerebral infarctions and gadolinium-enhanced lesions in both cerebral hemispheres. Her symptoms once improved after starting steroid treatment; however, soon developed consciousness disturbance and hemiparesis on the left side. She was referred to our hospital where she underwent stereotactic needle biopsy, that revealed an intravascular large B-cell lymphoma in the cerebrum. She received high-dose methotrexate chemotherapy followed by whole-brain radiation therapy, and the MR findings improved. However, her medical condition gradually worsened, and she died 6 months after disease onset. Intravascular lymphoma (IVL) limited to the central nervous system (CNS) is very rare, and the optimal treatment for this medical condition has not been established yet. IVLs showing only neurologic manifestations might be overlooked or misdiagnosed as cerebral infarctions. Here, we present a case of CNS IVL, with its radiographic and pathologic features and treatment with high-dose methotrexate chemotherapy.

Entities:  

Mesh:

Year:  2012        PMID: 23092108      PMCID: PMC4831244     

Source DB:  PubMed          Journal:  Nagoya J Med Sci        ISSN: 0027-7622            Impact factor:   1.131


  23 in total

1.  De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients.

Authors:  Motoko Yamaguchi; Masao Seto; Masataka Okamoto; Ryo Ichinohasama; Naoya Nakamura; Tadashi Yoshino; Junji Suzumiya; Takuhei Murase; Ikuo Miura; Takashi Akasaka; Jun-ichi Tamaru; Ritsuro Suzuki; Yoshitoyo Kagami; Masami Hirano; Yasuo Morishima; Ryuzo Ueda; Hiroshi Shiku; Shigeo Nakamura
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

Review 2.  A new approach to the diagnosis and treatment of intravascular lymphoma.

Authors:  Joachim M Baehring; Janina Longtine; Fred H Hochberg
Journal:  J Neurooncol       Date:  2003-02       Impact factor: 4.130

3.  Bcl-6 predicts improved prognosis in primary central nervous system lymphoma.

Authors:  Oren Levy; Lisa M Deangelis; Daniel A Filippa; Katherine S Panageas; Lauren E Abrey
Journal:  Cancer       Date:  2008-01-01       Impact factor: 6.860

4.  Prognostic value of immunohistochemical profile and response to high-dose methotrexate therapy in primary CNS lymphoma.

Authors:  Hiroyuki Momota; Yoshitaka Narita; Akiko M Maeshima; Yasuji Miyakita; Aya Shinomiya; Takashi Maruyama; Yoshihiro Muragaki; Soichiro Shibui
Journal:  J Neurooncol       Date:  2009-12-13       Impact factor: 4.130

5.  Immunohistochemical analysis of adhesion molecules and matrix metalloproteinases in malignant CNS lymphomas: a study comparing primary CNS malignant and CNS intravascular lymphomas.

Authors:  Manabu Kinoshita; Shuichi Izumoto; Naoya Hashimoto; Haruhiko Kishima; Naoki Kagawa; Tetsuo Hashiba; Yasuyoshi Chiba; Toshiki Yoshimine
Journal:  Brain Tumor Pathol       Date:  2008-11-06       Impact factor: 3.298

6.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

Authors:  Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Randy D Gascoyne; Jan Delabie; German Ott; H Konrad Müller-Hermelink; Elias Campo; Rita M Braziel; Elaine S Jaffe; Zenggang Pan; Pedro Farinha; Lynette M Smith; Brunangelo Falini; Alison H Banham; Andreas Rosenwald; Louis M Staudt; Joseph M Connors; James O Armitage; Wing C Chan
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

7.  Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous system origin and peripheral nodal origin.

Authors:  Ching-Hung Lin; Kuan-Ting Kuo; Shih-Sung Chuang; Sung-Hsin Kuo; Julia Hueimei Chang; Kung-Chao Chang; Hui-Chen Hsu; Hwei-Fang Tien; Ann-Lii Cheng
Journal:  Clin Cancer Res       Date:  2006-02-15       Impact factor: 12.531

Review 8.  Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'.

Authors:  Andrés J M Ferreri; Elías Campo; John F Seymour; Rein Willemze; Fiorella Ilariucci; Achille Ambrosetti; Emanuele Zucca; Giuseppe Rossi; Armando López-Guillermo; Miguel A Pavlovsky; Marie-Louise Geerts; Anna Candoni; Maurizio Lestani; Silvia Asioli; Mario Milani; Miguel A Piris; Stefano Pileri; Fabio Facchetti; Franco Cavalli; Maurilio Ponzoni
Journal:  Br J Haematol       Date:  2004-10       Impact factor: 6.998

Review 9.  Intravascular malignant lymphomatosis with neurologic presentation: factors facilitating antemortem diagnosis.

Authors:  T Devlin; S Moll; C Hulette; J C Morgenlander
Journal:  South Med J       Date:  1998-07       Impact factor: 0.954

Review 10.  Angiotropic large cell lymphoma (ALCL): morphological, immunohistochemical and genotypic studies with analysis of previous reports.

Authors:  P Domizio; P A Hall; F Cotter; S Amiel; J Tucker; G M Besser; D A Levison
Journal:  Hematol Oncol       Date:  1989 May-Jun       Impact factor: 5.271

View more
  6 in total

1.  Intravascular lymphoma: an unusual cause of rapid cognitive decline and the role of brain biopsy.

Authors:  Sujata Chaturvedi; Ishita Pant; Suman Kushwaha; Deepak Kumar Jha
Journal:  BMJ Case Rep       Date:  2014-08-21

Review 2.  [Clinical and pathological characteristics of intravascular lymphomas].

Authors:  L Abraham; H Kreipe; P Raab; K Hussein
Journal:  Pathologe       Date:  2018-05       Impact factor: 1.011

Review 3.  Intravascular Lymphoma in the CNS: Options for Treatment.

Authors:  Damir Nizamutdinov; Nitesh P Patel; Jason H Huang; Ekokobe Fonkem
Journal:  Curr Treat Options Neurol       Date:  2017-08-23       Impact factor: 3.598

Review 4.  Rare central nervous system lymphomas.

Authors:  Furqaan Ahmed Kaji; Nicolás Martinez-Calle; Vishakha Sovani; Christopher Paul Fox
Journal:  Br J Haematol       Date:  2022-03-16       Impact factor: 8.615

5.  Intravascular CNS lymphoma: Successful therapy using high-dose methotrexate-based polychemotherapy.

Authors:  Sied Kebir; Klaus Kuchelmeister; Pitt Niehusmann; Michael Nelles; Young Kim; Sharmilan Thanendrarajan; Niklas Schäfer; Moritz Stuplich; Frederic Mack; Björn Scheffler; Horst Urbach; Martin Glas; Ulrich Herrlinger
Journal:  Exp Hematol Oncol       Date:  2012-12-05

6.  Autopsy-Proven Intravascular Lymphoma Presenting as Rapidly Recurrent Strokes.

Authors:  Daisuke Usuda; Masahisa Arahata; Rie Temaru; Yoshitsugu Iinuma; Tsugiyasu Kanda; Shinichi Hayashi
Journal:  Case Rep Oncol       Date:  2016-03-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.